Related Experiment Video
Updated: Jan 26, 2026

Forward Genetic Approaches in Chlamydia trachomatis
Published on: October 23, 2013
Obtaining an ELISA test based on a recombinant protein of Chlamydia trachomatis
María J de Haro-Cruz1, Sandra I Guadarrama-Macedo2, Marcela López-Hurtado2
1Department of Microbiology, Escuela Nacional de Ciencias Biológicas del Instituto Politécnico Nacional, Carpio y Pro. Plan de Ayala, Col. Casco de Sto. Thomas, C.P. 11340, Mexico City, México.
Abstract:
Chlamydia trachomatis is considered as a public health problem due to its high prevalence and increased rates of gynecological disorders. The major outer membrane protein (MOMP) of this bacterium is the most abundant protein in its membrane and has been evaluated not only as a vaccine development candidate but also is used in many diagnostic tests. The MOMP weighs 69 kDa and contains four variable segments (VS 1-4) separated by constant regions. Several research groups have developed recombinant single-variable segments of MOMP expressed in Escherichia coli cytoplasm. But, all variable segments have been used minimally for the diagnosis of a chlamydial infection. In this experiment, the authors obtained the recombinant MOMP of C. trachomatis (rMOMP) in E. coli rMOMP and extracted, purified, and partially characterized it. This was later used to identify anti-Chlamydia trachomatis antibodies in sera of infertile patients by immunodetection assays, enzyme-linked immunosorbent assay (ELISA), and indirect immunofluorescence tests. The ELISA test showed high sensitivity and low specificity of 100 and 58.3%, respectively. The above results obtained were linked to the cross-reactivity of antibodies against C. pneumoniae or C. psittaci. Hence, an evaluation was performed to obtain an optimized test for the diagnosis of C. trachomatis infection.
Insights
Chlamydia trachomatis infections are a public health concern. This study developed a recombinant major outer membrane protein (rMOMP) for improved diagnostic tests to detect anti-Chlamydia antibodies.
Area of Science:
- Microbiology
- Immunology
- Public Health
Background:
- Chlamydia trachomatis poses a significant public health challenge due to high prevalence and association with gynecological disorders.
- The major outer membrane protein (MOMP) is crucial for C. trachomatis diagnosis and vaccine development.
- Previous diagnostic efforts minimally utilized MOMP variable segments.
Purpose of the Study:
- To obtain and characterize recombinant MOMP (rMOMP) from C. trachomatis.
- To evaluate the diagnostic potential of rMOMP for detecting anti-Chlamydia antibodies in infertile patients.
- To optimize diagnostic tests for C. trachomatis infection.
Main Methods:
- Recombinant MOMP (rMOMP) of C. trachomatis was expressed in E. coli, extracted, purified, and characterized.
- Immunodetection assays, including ELISA and indirect immunofluorescence, were used to identify anti-C. trachomatis antibodies.
- ELISA sensitivity and specificity were assessed.
Main Results:
- The rMOMP was successfully obtained, purified, and characterized.
- ELISA demonstrated 100% sensitivity but only 58.3% specificity.
- Low specificity was attributed to cross-reactivity with antibodies against C. pneumoniae or C. psittaci.
Conclusions:
- The recombinant MOMP shows promise for C. trachomatis detection.
- Further optimization is needed to address cross-reactivity and improve diagnostic specificity.
- Developing a precise diagnostic test is essential for managing C. trachomatis infections.
Related Concept Videos
Bacterial Phylum Chlamydiae
Recombinant DNA
Homologous Recombination
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Viral Recombination
Overview of Transposition and Recombination

